
Please try another search
Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, rest of Asia, Africa, Australia, North America, the Middle East, and Europe. The company offers oral health, pain relief, wellness and nutrition, and respiratory health products, as well as over-the-counter pharmaceutical products. It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands. The company also exports its products to Vietnam, the Philippines, and East West Africa region. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023. Haleon Pakistan Limited was incorporated in 2015 and is headquartered in Karachi, Pakistan. Haleon Pakistan Limited is a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
Name | Age | Since | Title |
---|---|---|---|
Dilawar Meghani | - | 2020 | Finance Director, CFO & Executive Director |
Ayesha Aziz | - | 2022 | Independent Director |
Saadia Umar | - | 2025 | Independent Director |
Oussama Abbas | - | 2020 | Non-Executive Director |
Qawi Naseer | - | 2025 | CEO & Executive Director |
Rahat Kaunain Hassan | - | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review